In EPCs isolated from type 2 diabetic patients there is an inhibition of STAT5/PPARγ transcriptional complex, leading to inactivation of Cyclin D1 and cell cycle arrest. The gene discussed is STAT5A; the disease is type 2 diabetes mellitus.